What is the main business of Inzpiro?

The main business activity of Inzpiro focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 4, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Sienna 72, 00-833 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $4,702 in 2024, which is an increase of 204.6% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $1,292. For comparison, in 2023 the loss was $1,137, meaning the company increased its loss by 7.9%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $4,792 in 2024, representing 81% of all operating expenses.

Inzpirosp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-09-04

Share capital

5,000.00 PLN

Activity description

Inzpiro is a mental health clinic in Warsaw offering psychiatric consultations at Sienna 72 and online. It diagnoses and treats depression, mood disorders, anxiety and other mental health conditions, and refers patients for psychotherapy when needed.

Registered address

ul. Sienna 72/011, 00-833 Warszawa, Poland

Website

psychiatrzy.pl

Opening hours

Monday–Friday: 7:30–21:00

Phone

Social media

Electronic delivery address

AE:PL-75110-58795-CUBIJ-16

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 43 days early.

202501/07/2026
202412/05/2025
202311/06/2024
202230/06/2023
202112/07/2022
202007/06/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 63.45kMedianUSD 443.18kAverageUSD 1.74m

Net profit

This companyUSD 3.71kMedianUSD 14.27kAverageUSD 128.63k

Operating costs

This companyUSD 59.46kMedianUSD 395.77kAverageUSD 1.56m

Assets

This companyUSD 8.74kMedianUSD 173.69kAverageUSD 1.02m

Industry

Offer

Psychiatric consultations
Online psychiatric consultations
Home visits by a psychiatrist
Psychogerontological consultations
ASD and ADHD diagnosis
Mental health treatment

Website technology

Website

WordPress
Elementor

Analytics and marketing

Google Tag Manager

Authorized Representatives

Michał Fiałkowski – President of the Management Board

Wojciech Łukasz Tochman – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Michał Fiałkowskiage 45	50	$675.31	50%
Wojciech Łukasz Tochmanage 57	50	$675.31	50%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Almimedsp. z o.o.	$273,006.72	almimed.com
Orlik Zdrowie i Edukacjasp. z o.o.	$257,578.35	przychodnia-orlik.pl
Holispacesp. z o.o.	$207,485.21	holispace.com
Centrum Medyczne Astoriasp. z o.o.	$180,932.60	centrum-medyczne-astoria.pl
Axis Eyesp. z o.o.	$153,370.02	axiseye.pl
Nativis Clinicsp. z o.o. + limited partnership	$127,770.40	nativisclinic.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
WARS i Sawa Clinic 1sp. k.	$85,519.31	warsisawaclinic.pl
Neurodiagnostykasp. z o.o.	$75,311.98	neurodiagnostyka.com
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl

FAQ

Last updated: 2026-07-04